ROVAC CORP
10KSB, EX-27, 2000-11-01
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ROVAC CORP, 10KSB, 2000-11-01
Next: ROVAC CORP, 10KSB/A, 2000-11-01



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-END>                               JUL-31-2000
<CASH>                                          (1766)
<SECURITIES>                                         0
<RECEIVABLES>                                    24392
<ALLOWANCES>                                         0
<INVENTORY>                                       8427
<CURRENT-ASSETS>                                 32819
<PP&E>                                          132568
<DEPRECIATION>                                  126214
<TOTAL-ASSETS>                                  106476
<CURRENT-LIABILITIES>                          2663167
<BONDS>                                              0
                                0
                                    1200000
<COMMON>                                        399581
<OTHER-SE>                                   (4156272)
<TOTAL-LIABILITY-AND-EQUITY>                    106476
<SALES>                                          13410
<TOTAL-REVENUES>                                 63941
<CGS>                                            10658
<TOTAL-COSTS>                                   165504
<OTHER-EXPENSES>                                  3762
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (80646)
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (178447)
<EPS-BASIC>                                     (.004)
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission